Does testosterone therapy raise PSA?

Many men see a small rise in the first months of therapy, particularly those who started from genuinely low testosterone, and it generally reflects prostate tissue responding to having a normal androgen environment restored. That is the pattern the saturation model predicts, since the tissue is most responsive at the low end. A modest early rise that then settles is different from a steady climb across consecutive draws, and telling those apart requires a baseline and repeat measurements. What any specific change means for you is a question for the prescribing physician, not something to interpret from an article.

What can make a PSA reading falsely high?

Urinary tract infection and prostatitis are the biggest culprits and can raise a value substantially until the inflammation settles. Ejaculation within about 48 hours of the draw, a long cycling session, and a digital rectal exam performed immediately beforehand all nudge it upward. A recent prostate biopsy elevates it for weeks. This is why a single high reading is a reason to repeat the test under clean conditions at the same laboratory rather than a reason to conclude anything, and why timing the draw is worth the small amount of planning it takes.

Why is PSA velocity considered more useful than a single value?

Because men differ enormously in their baseline, and a value that is unremarkable for one man would be a meaningful change for another. Velocity looks at the direction and pace of movement across repeat draws, which sidesteps the problem of not knowing where a man started. It only works if the draws are consistent, meaning the same laboratory, the same assay, and comparable conditions each time. Two readings taken at different labs can differ by enough to manufacture a trend that does not exist, which is a common source of unnecessary alarm.

Does finasteride affect how I should read my PSA?

Substantially. Finasteride and dutasteride reduce PSA by roughly half over several months of use, so a value that looks comfortable may be masking a higher underlying number. Physicians account for this when interpreting results, which is why it is important that the prescriber knows you are taking it, including when it was started for hair loss rather than for urinary symptoms. Saw palmetto is worth mentioning for the same reason. The practical risk is a real change hiding inside a value that still sits in a reassuring range.

What is free PSA percentage and when is it used?

PSA circulates both bound to proteins and unbound, and free PSA percentage is the share travelling unbound. It is used to add context to a total PSA that is already elevated, helping to refine how that elevation should be interpreted rather than serving as a standalone screening test. It is most useful in the borderline range where a total value alone leaves the picture ambiguous. Ordering it and interpreting it is a physician's decision based on the total result and the wider clinical picture.

Should I have a baseline PSA before starting testosterone therapy?

A prostate assessment before starting is standard practice in the guidelines physicians work from, and the baseline PSA is central to it. The reason is straightforward. Without a starting value there is no way to distinguish a man who has always run at a given level from a man who climbed to it, and that distinction is exactly what monitoring exists to detect. The measurement cannot be recreated afterward. What the baseline shows, and whether therapy is appropriate at all, is determined by the evaluating physician.

How often should PSA be checked on testosterone therapy?

The interval is set by the prescribing physician and depends on age, baseline value, family history, symptoms, and how long therapy has been running. A common general shape is a baseline before starting, a recheck within the first six to twelve months, and periodic monitoring thereafter alongside the other markers followed on therapy. The specific schedule is a clinical decision rather than a fixed rule, and the more important point is that monitoring continues rather than quietly lapsing once early results look settled.

testosterone24

PSA on TRT: The Prostate Number Men Misread in Both Directions

Back to Articles

Hormones 12 min read Aug 18, 2026

PSA on TRT: The Prostate Number Men Misread in Both Directions

Why a single PSA value is close to meaningless, and what turns it into information worth having.

A man starting testosterone therapy at 51 gets a baseline PSA of 1.4. Nine months later it reads 1.9, and the number sits on the page like an accusation. He spends a week convinced the therapy did something to him. What nobody explained is that a single PSA value carries almost no information on its own, that the reading moves for a long list of unremarkable reasons, and that the thing worth watching was never the number itself.

Prostate specific antigen is a protein made by the prostate gland, and a small amount of it leaks into the bloodstream in every man who has a prostate. That is the whole of what the test measures. It is not a cancer test, despite being treated as one in almost every conversation men have about it. It is a measurement of how much of one particular prostate protein is circulating, and the reason it earned its place on a panel is that several different prostate conditions can push that amount upward. Distinguishing between those conditions is the part the number cannot do by itself.

For men on testosterone therapy, or considering it, PSA carries an extra weight it does not carry for anyone else. The received wisdom for decades was that testosterone feeds the prostate and that raising it is asking for trouble. That belief shaped how a generation of physicians handled the question, and it still shapes how men react to their own results. The evidence underneath it has been reexamined fairly thoroughly, and the picture that came out is more specific and considerably less dramatic than the folklore. It is also frequently misreported in the other direction, which is its own problem.

Organ

What PSA Is Specific To

the marker is specific to prostate tissue, not to any one prostate condition, which is the distinction most men are never told about

Trend

What Carries the Information

the direction and pace of change across repeat draws says far more than any single value read in isolation

48 h

How Easily It Moves

cycling, sex, a recent digital exam, or a urinary infection can all shift a reading, which is why timing the draw matters

Baseline

The Draw Men Skip

a PSA taken before starting therapy is what makes every later value interpretable, and it cannot be recreated afterward

Why One PSA Value Tells You So Little

The core problem is that PSA is organ specific rather than disease specific. Prostate tissue makes it, and anything that irritates, enlarges, or inflames that tissue can raise the amount reaching the blood. Benign prostatic hyperplasia, the ordinary age-related enlargement that most men develop eventually, raises PSA simply because there is more gland producing it. Prostatitis raises it. A urinary tract infection raises it, sometimes substantially. Cancer raises it too. The test cannot tell you which of those it is looking at, and reading a value as though it can is where most of the fear comes from.

Running the other way, plenty of things lower a reading without anything improving. Finasteride and dutasteride, which many men take for hair loss or urinary symptoms, roughly halve PSA over several months. A man on finasteride whose PSA reads 1.2 is carrying a number that would read closer to 2.4 without the drug, and if nobody adjusts for that, a meaningful rise can hide inside a value that still looks comfortable. Obesity dilutes PSA across a larger blood volume and pushes readings down for reasons that have nothing to do with the prostate. Context changes what the same number means.

What Sits Behind an Elevated PSA Reading in Men Over 45 (Illustrative)

Benign prostatic enlargement, the most common single explanation
Prostatitis and other inflammation of the gland
Recent activity, ejaculation, cycling, or a recent exam
Urinary tract infection or recent instrumentation
Findings that turn out to warrant further investigation

Those proportions are a rough weighting drawn to make a point about how crowded the field is, not a measured epidemiological breakdown, and the mix shifts considerably with age and with how high the reading actually is. The reason to look at the shape rather than the slices is that the majority of raised PSA results in men this age trace back to something benign. That is not a reason to ignore a result. It is a reason to treat a single elevated value as the opening of an investigation rather than the conclusion of one, which is exactly the opposite of how most men experience it.

The Testosterone Question and What Actually Changed

The fear that testosterone drives prostate growth traces back to work from the 1940s showing that castration caused advanced prostate cancer to regress and that giving testosterone to those same men made things worse. Both observations were correct. The leap that followed, that more testosterone in any man means more prostate risk, did not follow from the data, and it went unchallenged for a long time because it sounded reasonable and nobody had a better model.

What emerged later is usually described as the saturation model. Prostate tissue depends on androgens, but the receptors involved appear to saturate at fairly low testosterone concentrations. Below that point the tissue is genuinely sensitive to how much testosterone is available. Above it, adding more produces very little additional effect because the receptors are already occupied. That framing explains why castrate-level men respond dramatically to changes and why moving a man from the low end of the normal range to the middle of it does much less than the old model predicted. It is a model rather than a settled law, and it does not make anyone exempt from monitoring.

The Saturation Idea, Shown as a Shape Rather Than as Data (Illustrative)

Androgen effect on prostate tissue
Circulating testosterone

The lines above are a schematic drawn to show a relationship, not measured values, and no threshold in any individual man sits where the chart puts it. The instructive part is the divergence. The blue line rises steadily because it is just testosterone concentration. The gold line climbs steeply at the bottom and then flattens, because the receptors it depends on fill up. Where the two lines run together, at the far left, changes in testosterone matter a great deal to the tissue. Where the gold line has gone flat, further increases buy the prostate very little. That gap is the entire argument, and it is also why the conversation is about monitoring rather than about avoidance.

The Prostate Markers and What Each One Can and Cannot Answer

Marker	What It Measures	Why It Gets Misread	What It Cannot Tell You
Total PSA	The overall amount of prostate specific antigen circulating in the blood	It is treated as a cancer test when it is a prostate tissue test with several possible explanations	Which prostate condition produced the number, which is the question men actually want answered
Free PSA percentage	The share of PSA circulating unbound to protein, reported as a percentage of the total	It is skipped entirely, so a borderline total gets acted on without the context that refines it	A verdict on its own, since it is used to sharpen the read on an already elevated total
PSA velocity	How fast the value is changing across repeat draws over time	It is calculated from two readings taken on different assays or at different labs, which corrupts it	Anything reliable without several consistent draws spaced properly apart
PSA density	The PSA value set against prostate volume measured on imaging	It requires a volume measurement that most men have never had, so it is quietly dropped	Anything without imaging, which puts it beyond a routine blood panel
Digital rectal exam	The physical size, texture, and symmetry of the gland as felt by a physician	Men avoid it, and it also raises PSA briefly if the blood is drawn immediately afterward	The inner regions of the gland that cannot be reached by examination
Urinary symptom score	A structured account of stream, frequency, urgency, and night-time waking	It is dismissed as subjective when it tracks the everyday burden better than any lab value	Anything about what is causing the symptoms, only how much they are costing you

Why the Baseline Draw Is the One That Matters Most

The single most useful PSA a man on testosterone therapy will ever have is the one taken before he starts. Every later value is interpreted against it, and without it there is no way to distinguish a man who has always run at 2.1 from a man who climbed to 2.1 over eighteen months. Those two situations look identical on a single report and mean entirely different things. A baseline cannot be reconstructed after the fact, and men who skip it spend the following years reading their results with the most informative comparison missing. If therapy is being considered, that draw belongs in the workup before the first dose, not after.

Separating Enlargement From Everything Else

Most men over 50 with urinary complaints are dealing with benign enlargement, and the symptom pattern it produces is reasonably characteristic. The gland sits around the urethra, so as it grows it squeezes the tube rather than blocking it outright. That mechanical detail explains most of what men notice, and it is worth knowing because it makes the difference between a symptom that fits an ordinary picture and one that does not.

A weak or hesitant stream that takes a moment to start fits the mechanical squeeze of an enlarging gland
Waking once or twice a night to urinate is common with enlargement and also has causes that have nothing to do with the prostate
A sense of incomplete emptying, followed by needing to go again shortly after, is a classic enlargement complaint
Symptoms that came on gradually across years fit the slow growth pattern better than anything that arrived over weeks
Blood in the urine or semen, bone pain, or unexplained weight loss are not part of the ordinary enlargement picture and warrant prompt medical attention
Burning, fever, or pelvic pain point toward infection or inflammation rather than growth, and both raise PSA in their own right

How Much Everyday Things Can Shift a PSA Reading (Illustrative Weighting)

A Sensible Order for Working the Question

Draw a Baseline Before Anything Starts

Get total PSA before the first dose of therapy, with no ejaculation, hard cycling, or rectal exam in the two days beforehand, so the number is clean and the comparison exists later

→

↓

Repeat Before Reacting

A single elevated value is a reason to repeat the test at the same laboratory after any infection has cleared, not a reason to draw conclusions or stop anything on the spot

→

↓

Add the Context Markers

Where a repeat confirms the rise, free PSA percentage, the symptom picture, and an examination give the total value the context it lacks on its own

→

↓

Escalate Through a Physician

Imaging, urology referral, and any decision about biopsy belong with a physician who has the full history, and are not conclusions a man should reach from a lab report alone

What Monitoring Actually Looks Like

The practical value of PSA on therapy comes almost entirely from consistency. Two draws taken at the same laboratory, on the same assay, timed the same way relative to activity, produce a comparison that means something. Two draws taken at different labs eighteen months apart produce a difference that might be the prostate and might be the assay. Most of the alarm men experience over a small change comes from comparisons that were never valid to begin with, and fixing that costs nothing beyond a little planning.

Use the same laboratory for every draw, because assay differences between labs can exceed the change you are trying to detect
Avoid ejaculation, hard cycling, and rectal examination for 48 hours before the blood is taken
Postpone the draw if there is an active urinary infection or any pelvic inflammation, since the result will be uninterpretable
Tell the physician about finasteride, dutasteride, or saw palmetto, all of which affect how the number should be read
Keep the actual values written down rather than relying on being told everything looked fine, since the trend is the point
Any decision to start, adjust, or stop testosterone therapy on the basis of a PSA result is a physician's call after evaluation, not a self-directed one

The First Twelve Months of Monitoring

Before the first dose

✓Draw a baseline total PSA under clean conditions, meaning no ejaculation, cycling, or rectal exam in the preceding 48 hours
✓Record a urinary symptom picture in writing, covering stream, frequency, urgency, and night-time waking, so later changes are comparable
✓List every medication and supplement that touches the prostate, particularly finasteride, dutasteride, and saw palmetto
✓Have the physical examination done as part of the workup rather than deferring it, since it answers questions the blood test cannot

Months 3 to 6

✓Repeat PSA at the same laboratory under the same conditions, alongside the other markers being followed on therapy
✓Compare against the baseline value rather than against a published reference range, since your own starting point is the relevant benchmark
✓Recheck the urinary symptom picture against what was written down before starting, rather than trusting a recollection
✓Treat any single surprising value as a prompt to repeat the test rather than as a result to act on immediately

Months 9 to 12

✓With three or more consistent draws in hand, the pace of change becomes readable in a way no single value ever was
✓A stable trend with stable symptoms is the ordinary outcome and is what routine monitoring is designed to confirm
✓A steady climb across consecutive draws is a reason to involve a physician early, while the numbers are still small and the picture is clear
✓Agree the ongoing monitoring interval with the prescribing physician rather than letting the schedule quietly lapse once things look settled

The argument here is narrow. It is not that PSA is unimportant, and it is certainly not that men on testosterone therapy can skip it. It is that the number is routinely asked to answer a question it was never built to answer, and that the men who get the most out of it are the ones who treat it as a line on a graph rather than a verdict on a page. A man who has four consistent readings and a written symptom history has something genuinely useful. A man staring at one value with nothing to compare it against has a source of anxiety and very little else.

Medical Disclaimer

This article is for educational purposes only and is not medical advice. Nothing here diagnoses, treats, cures, or prevents any disease, including prostate cancer, benign prostatic hyperplasia, prostatitis, or hypogonadism. PSA interpretation, prostate screening decisions, and testosterone therapy all require evaluation and ongoing management by a licensed physician who knows your history. Testosterone is a prescription medication in most jurisdictions, and decisions to start, adjust, or stop it must never be made on the basis of an article or a laboratory value read without clinical context. The charts and weightings shown here are illustrative demonstrations of directional relationships and are not study results, epidemiological data, or predictions about any individual. Laboratory reference ranges and PSA assays differ between providers, and no figure in this article should be compared against a personal lab report. Urinary symptoms, blood in the urine or semen, pelvic pain, and unexplained weight loss have many possible causes and require prompt medical evaluation. Speak with a licensed physician about your symptoms, your bloodwork, and your medical history before making any decision.